Acquired (autoimmune) hemophilia: demographics, outcomes, and readmissions
Blood Vessels, Thrombosis & Hemostasis · 2025-05 · 2 (2) · 100062
DOI: 10.1016/j.bvth.2025.100062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Vessels, Thrombosis & Hemostasis, 2025-05. Verfasst von Aditi Sharma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Karmanos Cancer Institute/Wayne State University School of Medicine, Detroit, MI. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Oncology, Karmanos Cancer Institute/Wayne State University School of Medicine, Detroit, MI.
- Department of Internal Medicine, Trinity Health Oakland/Wayne State University School of Medicine, Pontiac, MI.
Zitieren
APA
Sharma, A., Vojjala, N., & Singh, V. (2025). Acquired (autoimmune) hemophilia: demographics, outcomes, and readmissions. Blood Vessels, Thrombosis & Hemostasis, 2(2), 100062. https://doi.org/10.1016/j.bvth.2025.100062
Vancouver
Sharma A, Vojjala N, Singh V. Acquired (autoimmune) hemophilia: demographics, outcomes, and readmissions. Blood Vessels, Thrombosis & Hemostasis. 2025;2(2):100062. doi:10.1016/j.bvth.2025.100062
BibTeX
@article{Sharma2025,
author = {Sharma, Aditi and Vojjala, Nikhil and Singh, Vijendra},
title = {Acquired (autoimmune) hemophilia: demographics, outcomes, and readmissions},
journal = {Blood Vessels, Thrombosis & Hemostasis},
year = {2025},
volume = {2},
number = {2},
pages = {100062},
doi = {10.1016/j.bvth.2025.100062}
}
EUVIMED